Lv2
178 积分 2024-10-13 加入
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
1个月前
已完结
Topical Symposia
5个月前
已关闭
AYVM to AYMM transition on HER2 exon 20 insertion induces TKI resistance in NSCLC
11个月前
已完结
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy
1年前
已完结
Neratinib in Combination With Trastuzumab for the Treatment of Patients With Advanced HER2-positive Breast Cancer: A Phase I/II Study
1年前
已完结
A randomized phase 2 study of neratinib with or without fulvestrant for patients with HER2-positive, estrogen receptor-positive metastatic breast cancer
1年前
已完结
Targeted delivery of neratinib/xanthan gum-capped calcium carbonate nanoparticles induces apoptosis through PI3K/AKT pathway in breast cancer mice model
1年前
已关闭
Molecular Classification of Breast Cancer
1年前
已完结
皖公网安备34019202002308
